RAPGEF3 and Other metabolic disease: Using human brown fat organoids, Reverte-Salisa’s research showed that EPAC1 can increase the proliferation and differentiation of brown fat cells, suggesting that EPAC1 may have the potential to increase energy expenditure and thereby combat metabolic diseases (Reverte-Salisa et al., 2024).